TM-38837
id:
tm-38837-298-5426525
title:
TM-38837
text:
TM-38837 is a small molecule inverse agonist/antagonist of the CB1 cannabinoid receptor, with peripheral selectivity. It is being developed for the treatment of obesity and metabolic disorders by 7TM Pharma. The company has announced phase I clinical trials. TM-38837 is among the first of a new generation of cannabinoid receptor antagonist designed to avoid the central nervous system liabilities of the first generation CB1 receptor antagonists such as rimonabant.
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/TM-38837
date created:
date modified:
2023-11-07T06:53:22Z
main entity:
{"identifier":"Q7670627","url":"https://www.wikidata.org/entity/Q7670627"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/2/2f/TM-38837.svg","width":512,"height":518}
fields total:
13
integrity:
15